Professor Mark Pritchard BSc, MBChB(hons), FRCP(UK), PhD

Research Grants

Bench fees for Mr Esam Meftah Ali Shahout (201117020)

LIBYAN EMBASSY IN LONDON🚩

December 2019 - November 2023

Bench Fees for Sumeia Ghannay (201382673)

LIBYAN EMBASSY IN LONDON🚩

January 2021 - January 2023

Investigation of the importance of gastrin/cholecystokinin-2 receptor expression and of its inhibition by netazepide in gastric and duodenal neuroendocrine tumours.

TRIO MEDICINES LIMITED (UK)

August 2018 - January 2021

Study to determine the effect of ferric maltol on gut microbiota in inflammatory bowel disease patients with iron deficiency

SHIELD THERAPEUTICS PLC (UK)

January 2018 - January 2019

MECNUT: Impact of dietary exposure to emulsifiers on the intestinal mucosa - implications for inflammatory bowel disease and metabolic syndrome

MEDICAL RESEARCH COUNCIL

November 2017 - September 2021

Investigating the impact of Streptococcus gallolyticus infection on epithelial cell turnover in an enteroid model

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

January 2017 - January 2018

Investigation of a novel gastrin receptor antagonist

TRIO MEDICINES LIMITED (UK)

October 2015 - September 2019

Targeting intestinal epithelial cell shedding using NF-kB inhibitors to ameliorate sepsis

FIONA ELIZABETH AGNEW TRUST (UK)

June 2016 - May 2017

Gastrin and C-Kit in Gastric Cancer.

ROYAL SOCIETY (CHARITABLE)

September 2000 - August 2001

Genetics of non-steroidal anti-inflammatory drugs (NSAIDs)-induced peptic ulceration: a genome wide association study.

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

July 2010 - June 2011

Identification of patients at risk of gastric cancer

NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)

February 2014 - January 2015

Role of MMP-7 in the pathogenesis of gastric cancer.

NORTH WEST CANCER RESEARCH FUND

November 2003 - November 2006

The role of NF-kB and cell shedding in inflammatory Bowel Disease

WELLCOME TRUST (UK)

August 2011 - May 2014

Validation and exploitation of biomarkers for identification of patients at risk of gastric cancer

NORTH WEST CANCER RESEARCH FUND

November 2012 - October 2014

Development of primary cultures of human colonic epithelium.

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

September 2005 - August 2007

Mechanisms of promotion of colorectal carcinogenesis by the non-amidated precursors of gastrin in vitro and in vivo.

NORTH WEST CANCER RESEARCH FUND

January 2001 - August 2004

Identification of patients at risk of gastric cancer due to helicobacter pylori infection

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

September 2007 - March 2012

Epithelial cell shedding induced gut barrier dysfunction

LIBYAN EMBASSY IN LONDON🚩

October 2014 - September 2015

Role of NF-kappaB signalling in acute experimental pancreatitis

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

March 2014 - February 2015

Investigation of the mechanisms by which progastrin promotes colonic carcinogenesis.

NORTH WEST CANCER RESEARCH FUND

June 2006 - December 2010

Investigation of the intestinal microbiome of mice which have aberrant NF-kappaB signalling

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

August 2014 - July 2015

Bridging and accelerating the translation of novel scientific findings for health and wealth gain

MEDICAL RESEARCH COUNCIL

March 2014 - August 2015

Investigation of the importance of individual members of the Nuclear Factor-kappaB (NF-kB) family during Helicobacter pylori-induced gastric carcinogenesis

WELLCOME TRUST (UK)

April 2008 - March 2011

Towards disease diagnosis through spectrochemical imaging of tissue architecture.

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL

June 2013 - September 2016

Assessment of the abundance of potential biomarkers of colorectal neoplasia in human patients

CANCER RESEARCH UK (UK)

July 2010 - September 2011

Importance of alternative pathway NF-κB signalling in Helicobacter-induced gastric carcinogenesis

NORTH WEST CANCER RESEARCH FUND

January 2013 - September 2016

How does the gastrin/CCK-2 receptor antagonist netazepide (YF476) alter gastric mucosal gene expression in patients with type I gastric neuroendocrine tumours?

UKI NETS (UK)

January 2014 - December 2014

The role of NF-kB and cell shedding in Inflammatory Bowel Disease.

WELLCOME TRUST (UK)

September 2009 - September 2012

Pathogenesis of type 1 gastric carcinoid tumours.

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

September 2006 - August 2008

Investigation of the importance of the gastrin family of peptides and gastrin/CCKb receptor in inflammatory bowel disease.

NAT ASSOC FOR COLITIS & CROHNS DISEASE (UK)

September 2003 - September 2007

Systems medicine of chronic inflammatory bowel disease (SysmedIBD)

EUROPEAN COMMISSION

December 2012 - November 2017

Gastrin and its receptor inflammatory bowel disease.

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

September 2003 - February 2007

Investigation of the genetic regulation of apoptosis in the stomach, with particular reference to the development of gastric atrophy.

WELLCOME TRUST (UK)

September 2002 - December 2007

Characterisation and assessment of the functional impact on gastric preneoplasia of the non-Helicobacter gastric dysbiosis of Nfkb1-/- and Nfkb2-/- mice

GUTS (UK CHARITY)

February 2014 - January 2015

How does the microbiome of the hypochlorhydric stomach promote gastric tumourigenesis?

WORLDWIDE CANCER RESEARCH (UK)

November 2012 - October 2015